Table 1:
Patient | Age/ Gender | Implant/#electrodes | FBTCS type | SOZ | IPA (s) | Gamma % channels |
---|---|---|---|---|---|---|
1 | 20/M | LFT/84 | 1,1 | LT | 44,45 | 100,100 |
2 | 50/M | BFT/32 | 1,3 | RF(1) RFT(1) | 100,60 | 100,100 |
3 | 19/F | RH/126 | 3,1b | RO | 27,66b | 52,8b |
4 | 30/F | LH/121 | 3,3 | LFT | 20,28 | 68,24 |
5 | 25/M | LFT/56 | 3 | LT | 49 | 79 |
6 | 22/M | RFTP/102 | 3b,3,3b | RF | 10b,40,15b | 3b,59,2b |
7 | 20/F | LP/48 | 3 | LP | 4 | 57 |
8 | 23/M | BFTCa/126 | 3,1,1 | RT(2) LT(1) | 45,40,51 | 100,100,100 |
9 | 30/F | LFTa/110 | 3,1 | LF | 34,33 | 100,100 |
10 | 25/M | LT/RFTa/126 | 3,3 | RT | 42,20 | 66,79 |
11 | 37/M | RTPO/78 | 1 | RT | 49 | 69 |
12 | 32/F | LFT/84 | 1b | LT | 48b | 93b |
13a | 34/M | LT/50 | 1,2 | LT | 27,0d | 93, no IPA |
13b | 35/M | LT/72 | 2 | LT | 2 | 100 |
14 | 37/M | RFT/128 | 1,2b | RF | 34,0b | 98, no IPAb |
15 | 16/M | RH/70 | 3,3,3 | RT | 8,0,0 | c, no IPA, no IPA |
16 | 22/F | LH/110 | 2 | LT | 0d | no IPA |
FBTCS=focal to bilateral tonic-clonic seizure, SOZ=seizure onset zone, IPA=intracranial postictal attenuation, L=left, R=right, B=bilateral, F=frontal, T=temporal, C=central, P=parietal, O=occipital, H=hemispheric
=stereo EEG implant
=provoked seizure
=excluded from analysis due to preictal baseline EEG <5 minutes
=partial postictal attenuation